Chronic Hepatitis B, C Linked With Lymphoma in HIV Patients
This Medical News Minute examines a recent report that found that chronic infection with hepatitis B or C virus was associated with an increased risk for lymphoma among HIV patients on antiretroviral therapy.
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara examines a new study that found that chronic infection with hepatitis B or C virus was associated with an increased risk for non-Hodgkin lymphoma among HIV patients on antiretroviral therapy.
Among treatment-naive patients, the hazard ratio (HR) for non-Hodgkin lymphoma with hepatitis B was 1.33 (95% CI, 0.69–2.56) and with hepatitis C was 0.67 (95% CI, 0.40–1.12). Among treated patients, the HR with hepatitis B was 1.74 (95% CI, 1.08–2.82) and with hepatitis C was 1.73 (95% CI, 1.21–2.46).
![We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fd5a069c33bbfe917bc7c0b1bb13d76c0a815cc44-234x234.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.")
